What is Broad Institute?
Founded in 2004 and headquartered in Cambridge, Massachusetts, Broad Institute is a leading research organization dedicated to understanding the genetic basis of human diseases and developing innovative treatments. By leveraging the power of genomics, the institute aims to translate scientific discoveries into tangible therapies, positioning itself at the forefront of biomedical innovation. Its work spans fundamental biological research to the application of genomic insights for drug discovery and personalized medicine.
How much funding has Broad Institute raised?
Broad Institute has raised a total of $132.5M across 2 funding rounds:
Unspecified
$32.5M
Unspecified
$100M
Unspecified (2012): $32.5M with participation from Klarman Family Foundation
Unspecified (2013): $100M led by Edythe Broad and Eli Broad
Key Investors in Broad Institute
Eli Broad
Eli Broad was a prominent businessman and philanthropist known for his significant contributions to education, science, and the arts. His investments often focused on addressing societal challenges and fostering civic engagement, reflecting a deep commitment to community betterment and scientific advancement.
Klarman Family Foundation
The Klarman Family Foundation is dedicated to identifying and addressing areas of unmet need, with a focus on advancing biological understanding of health and illness. They collaborate with other funders to maximize impact, particularly in scientific research and community enrichment.
What's next for Broad Institute?
The substantial enterprise-level funding and strategic investments indicate a robust commitment to Broad Institute's long-term mission. This capital infusion is expected to accelerate ongoing research initiatives, expand its genomic capabilities, and foster new collaborations in the pursuit of novel treatments for a wide range of human ailments. The institute is poised to continue its impactful contributions to medical science and public health.
See full Broad Institute company page
